These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 7349901)
1. An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture. Whitehead JS; Kim YS Cancer Res; 1980 Jan; 40(1):29-35. PubMed ID: 7349901 [TBL] [Abstract][Full Text] [Related]
2. In vitro expression of suppressogenic and enhancing activities in human colon cancer cells. Tom BH; Macek CM; Subramanian C; Miller AL; Sengupta J J Biol Response Mod; 1984 Aug; 3(4):435-44. PubMed ID: 6481402 [TBL] [Abstract][Full Text] [Related]
3. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. Li J; Hu P; Khawli LA; Epstein AL Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000 [TBL] [Abstract][Full Text] [Related]
4. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
5. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of production of superoxide anion by human polymorphonuclear leukocytes exposed to products of the HT-29 human colonic adenocarcinoma cell line. Bettetini D; Garrouste F; Remacle-Bonnet M; Culouscou JM; Marvaldi J; Pommier G J Natl Cancer Inst; 1986 Dec; 77(6):1225-34. PubMed ID: 3025499 [TBL] [Abstract][Full Text] [Related]
7. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Semple TU; Quinn LA; Woods LK; Moore GE Cancer Res; 1978 May; 38(5):1345-55. PubMed ID: 565251 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of normal allogenic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma. Remacle-Bonnet MM; Pommier FJ; Kaplanski S; Rance RJ; Depieds RC J Immunol; 1976 Oct; 117(4):1145-51. PubMed ID: 977947 [TBL] [Abstract][Full Text] [Related]
9. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834 [TBL] [Abstract][Full Text] [Related]
10. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma. Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233 [TBL] [Abstract][Full Text] [Related]
11. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model. Jack AM; Aydin N; Montenegro G; Alam K; Wallack M J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030 [TBL] [Abstract][Full Text] [Related]
12. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Kikuchi T; Miyazawa N; Moore MA; Crystal RG Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803 [TBL] [Abstract][Full Text] [Related]
13. Nonspecific suppressive and cytostatic activities mediated by human colonic carcinoma tissue or cultured cell extract. Remacle-Bonnet MM; Pommier GJ; Luc C; Rance RJ; Depieds RC J Immunol; 1978 Jul; 121(1):44-52. PubMed ID: 670707 [TBL] [Abstract][Full Text] [Related]
14. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067 [TBL] [Abstract][Full Text] [Related]
15. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240 [TBL] [Abstract][Full Text] [Related]
16. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Ogawa H; Nishihira J; Sato Y; Kondo M; Takahashi N; Oshima T; Todo S Cytokine; 2000 Apr; 12(4):309-14. PubMed ID: 10805210 [TBL] [Abstract][Full Text] [Related]
17. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805 [TBL] [Abstract][Full Text] [Related]
18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
19. Participation of pterins in the control of lymphocyte stimulation and lymphoblast proliferation. Ziegler I; Hamm U; Berndt J Cancer Res; 1983 Nov; 43(11):5356-9. PubMed ID: 6577948 [TBL] [Abstract][Full Text] [Related]
20. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]